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Penilaian Menggunakan Kaedah Sekuensial Bercampur Ke Atas 
Pengamal Perubatan Umum, Ahli Farmasi, Konsumer dan Pelajar 
Farmasi Berkaitan Isu-Isu Kotemporari Sekitar Penggunaan Ubat 
Generik di Karachi, Pakistan 
 
ABSTRAK 
 
Negara membangun sedang bergelut dengan kos rawatan yang tinggi dan Pakistan 
juga tidak terlepas daripada isu ini. Ubat generik boleh memainkan peranan penting 
dalam mengurangkan kos rawatan serta perbelanjaan penjagaan kesihatan di 
Pakistan.  Oleh itu, penting bagi memastikan pengetahuan, persepsi  dan sikap 
pemegang taruh dalam hal ini. Kajian ini menggunakan penyelidikan kaedah-campur 
berjujukan yang mengaplikasikan pendekatan kualitatif dan kuantitatif.  Data 
kualitatif  dikumpul  berdasarkan temu bual separa-struktur  secara bersemuka 
dengan pengamal perubatan (general practitioners, GP), ahli farmasi, pengguna dan 
pelajar farmasi. Takat maksimum, suatu puncak yang tiada lagi maklumat baru 
diperoleh daripada temu bual tambahan, dicapai pada 11 bagi doktor, 11 bagi ahli 
farmasi, 29 bagi pengguna dan 28 bagi pelajar farmasi.  Gabungan tema a priori dan 
tema daripada analisis memberikan maklumat tentang tahap pengetahuan ubat 
generik dalam kalangan GP,  pengguna dan pelajar farmasi. Dari segi persepsi dan 
sikap, dengan mengabaikan pelajar, pendapat daripada pemegang taruh yang lain 
adalah pelbagai.  Soal selidik yang diolah berdasarkan keputusan kualitatif serta 
carian literatur, kemudiannya diuji dan disahkan sebelum diedarkan kepada 
responden kecuali pengguna. Bagi pengguna. temu bual berinstrumen digunakan.  
Empat soal selidik yang berbeza digunakan dalam bahagian kuantitatif  kajian ini. 
Statistik deskripsi dan statistik inferens yang sesuai  dijalankan dalam setiap 
bahagian kajian ini. Kesignifikanan tahap a priori 0.05 digunakan. Soal selidik bagi 
GP  diagihkan kepada 289 GP.  Sejumlah 206 GP (71.3%) telah melengkapkan soal 
 xxiv
selidik ini.  Lebih daripada 70% (n=148; 71.8%)  GP menunjukkan pemahaman yang 
betul bahawa ubat generik merupakan salinan daripada jenama ubat yang lain. 
Mereka juga menunjukkan  persepsi dan sikap yang baik tentang preskribsi  ubat. 
Lebih  separuh daripada respondan sangat bersetuju bahawa wakil perubatan 
merupakan sumber maklumat yang baik (n=158; 76.7%) dan mempengaruhi 
keputusan preskribsi  mereka (n=117; 56.8%). Soal selidik bagi ahli farmasi 
diedarkan  kepada 51 ahli farmasi komuniti dan 150 ahli farmasi hospital. Sejumlah 
152 (75.6%) soal selidik didapati berguna.  Ahli farmasi menunjukkan persepsi dan 
sikap yang baik tentang ubat generik dan gantiannya. Lebih dua pertiga daripada 
respondan (n=117; 77.0%) menyatakan bahawa ubat generik secara teraputik sama 
dengan nama ubat. Lebih daripada dua pertiga respondan berpendapat bahawa ubat 
buatan tempatan mempunyai kesan yang sama seperti ubat berjenama (n=123; 
80.9%) dan mereka lebih selesa untuk menukar nama jenama dalam preskripsi 
(n=138; 90.8%). Dalam bahagian ketiga kajian ini, sejumlah 300 soal selidik 
dijalankan secara temu bual dengan semua golongan pengguna, iaitu golongan 
berpendapatan tinggi, pertengahan dan rendah.  Sebahagian besar pengguna tidak 
pernah mendengar tentang istilah ubat generik (n=207; 69%). Sebilangan kecil 
(kurang daripada separuh) respondan bersetuju  (n=135; 44.0%)  bahawa ubat 
generik adalah sama efektif seperti ubat berjenama. Majoriti daripada mereka 
bersetuju (n=254; 84.7%)  bahawa preskribsi yang diberikan oleh doktor adalah yang 
terbaik bagi mereka. Dalam kajian di bilik darjah, sejumlah 236 soal selidik 
diedarkan dalam kalangan pelajar farmasi tahun akhir. Hanya separuh daripada 
respondan (n=118; 50.0%) menunjukkan pemahaman yang betul bahawa ubat 
generic mempunyai kesamaan biologi yang sama seperti ubat berjenama.  
Sehubungan dengan persepsi,  pelajar farmasi menunjukkan keprihatinan yang tinggi 
 xxv
tentang ubat generik dan menganggap diri mereka sebagai seorang daripada 
profesional penjagaan kesihatan yang penting untuk memberi nasihat tentang ubat 
generic (n=233; 98.8%).  Jurang atau tahap pengetahuan tentang ubat generak 
dikenal pasti dalam kalangan pemegang taruh. Persepsi dan sikap yang baik dikenal 
pasti dalam kalangan profesional penjagaan kesihatan, pelajar farmasi dan pengguna 
tentang  penggunaan ubat generik. 
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An exploratory sequential mixed method evaluation of general 
practitioners, pharmacists, consumers and pharmacy students’ 
knowledge, perception and attitude on contemporary issues 
surrounding generic medicine use in Karachi,  Pakistan 
 
 
 
ABSTRACT 
 
 
Developing countries are struggling with the high cost of treatment and Pakistan is 
not an exception to this issue. Generic medicines could be instrumental in curtailing 
the cost of treatment and reduce healthcare expenditures in Pakistan. Therefore, it is 
imperative to ascertain the knowledge, perception and attitudes of different 
stakeholders in this regard. The study used a sequential mixed-method research in 
which the qualitative and quantitative approaches were applied.  The qualitative data 
was collected through in-depth semi-structured, face-to-face interviews with general 
practitioners, pharmacists, consumers, and pharmacy students. Saturation point, a 
peak after which no new information was sought from additional interviews, was 
achieved at 11 for doctors, 11 for pharmacists, 29 for consumers and 28 for 
pharmacy students. A combination of a priori themes and emergent themes from 
content analysis identified gaps in knowledge of generic medicines among general 
practitioners, consumers, and pharmacy students.  Likewise, in terms of perception 
and attitude, with the exception of students the opinions of all the stakeholders seem 
to be divided. The questionnaires which were formed on the basis of qualitative 
results as well as literature search were distributed and collected by hand after 
pretested and validated; except for consumers wherein interview-administered 
instrument was used. Four separate survey questionnaires were used in the 
quantitative part of the study.  Appropriate descriptive and inferential statistics were 
performed in each part of the study.  A priori significance level of 0.05 was used.  
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The survey questionnaire for general practitioners was distributed to 289 GPs. A total 
of 206 GPs (71.3%) completed the survey. More than 70% (n=148; 71.8%) of the 
general practitioners showed correct understanding that generic medicines are copy 
of the brand name medicines. General practitioners expressed good perception and 
attitude towards generic medicine prescribing. More than half of the respondents 
expressed their strong agreement that medical representative is a good source of 
information for them (n=158; 76.7%) and influence their prescribing decisions 
(n=117; 56.8%).  The survey questionnaire for pharmacists was distributed to 51 
community pharmacists and 150 hospital pharmacists. A total of 152 (75.6%) 
questionnaires were found to be usable. Pharmacists showed good perception and 
attitude towards generic medicine and its substitution. Two-thirds of the respondents 
(n=117; 77.0%) expressed their knowingness that generic medicines are 
therapeutically equivalent to brand name medicines. More than two-thirds of the 
respondents viewed that locally manufactured medicines are of same effectiveness as 
brand name medicines (n=123; 80.9%) and expressed their comforting attitude to 
change brand name in prescription (n=138; 90.8%).  In the third part of the study, a 
total of 300 questionnaires were interview-administered to high income group, 
middle income group, and low income group consumers. A very large majority of 
consumers never heard the term generic medicines (n=207; 69%). Slightly less than 
half of the respondents agreed (n=135; 44.0%) that generic medicines are as effective 
as brand medicines. A very large majority agreed (n=254; 84.7%) that their doctor 
prescribes the best medicine for them.  In a classroom survey, 236 questionnaires 
were distributed among final year pharmacy students. Only half of the respondents 
(n=118; 50.0%) showed correct understanding that generic medicines are 
bioequivalent to brand name medicines. With regard to perception, pharmacy 
 xxviii
students showed high concern towards generic medicine and viewed themselves as 
one of the most important healthcare professional to give advice on generic 
medicines (n=233; 98.8%).  Knowledge gaps were recognized among stakeholders 
towards generic medicines. Good perception and attitude were identified among 
healthcare professionals, pharmacy students and consumers towards generic 
medicine utilization. 
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General Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2
1.1 Introduction 
 
Medicines play a pivotal role in the process of human development as their rational 
utilization can decrease the morbidity and mortality as well as improve the quality of 
life (Cohen-Kohler, 2007). Healthcare expenditures become an increased burden and 
prices of medicines account for the majority of healthcare expenditures in developing 
countries (Quick, 1997). As price of medicine is one important obstacle to access of 
medicines (WHO, 2003), there seems to be inequitable access to medicines globally.  
World Health Organization (WHO) estimates that one third of the world population 
lacks access to essential medicines and more than 50% of the population of 
developing countries in Asia and Africa lacks access to basic essential medicines 
(WHO, 2004 ). In fact, access to medicines is characterized by many factors such as 
affordable prices, rational utilization, sustainable financing and reliable supply 
system but the most crucial element which restricts access to medicines is drug 
pricing (HAI, 2007). Therefore, to increase access to medicines, affordable price is 
one of the measures to counteract the global medicine gap. The issue of affordability 
is therefore, accordingly addressed by generic medicines, which is a cost 
containment strategy globally. 
1.2 Definition of generic medicine 
 
A “generic” medicine is a multisource pharmaceutical product which is meant to be 
interchangeable with the comparator product which is also known as proprietary, 
brand or innovator product (WHO, 2005). Interchangeable pharmaceutical products 
are considered to be therapeutically equivalent to innovator product i.e. when 
administered in the same dosage form and by the same route, they will produce the 
same desired effects exhibiting the same safety profile as innovator or brand product 
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(WHO, 2008b). Included in the definition of generic products are those marketed 
under a brand name, known as branded generics (Homedes & Ugalde, 2005). 
Generic medicine can also mean a product marketed under the drug’s non-
proprietary approved name, or it can mean a product marketed under a different 
brand (proprietary) name. It is, sometimes, used to mean any product from a 
company other than the innovator (research-based) manufacturer (Birkett, 2003). 
Generally, due to the cost effective nature, generic medicines offer major saving 
benefits in health-care expenditures (Hassali & Stewart 2004; Lofgren, 2004).  
1.3 Pakistan 
 
1.3.1 Demographics 
 
The Islamic Republic of Pakistan has an approximate population of 158 million 
(DFID, 2007) with a population growth rate of 2% per annum (Khan, 2006). 
However, according the recent report of Ministry of Population Welfare, Islamabad, 
Pakistan, the population has increased five folds since last six decades and is 
estimated to be 171 million in mid 2009 (NPP, 2010). As far as the demographic 
characteristics are concerned, the population comprises of native people with rich 
cultural and linguistic diversity. With its four administrative provinces Sind, Punjab, 
Balochistan and North West Frontier Province (NWFP), recently renamed as 
Pakhtoon Khawa, the population is showing an uneven appearance in distribution. In 
the eastern provinces of Punjab and Sind there is an estimated 78.6% population 
while Balochistan, although being 44% of the total land area of the country, has only 
5% of the population (Pakistan, 2008). 
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1.3.2 Healthcare system in Pakistan 
 
The responsibility of Government of Pakistan is to give free national health care 
services to all strata of society including hospital care free of charge (Pakistan, 2005) 
The Ministry of Health is responsible in providing services, both curative as well as 
preventive but the recent institutional reform provides mandate to provinces for 
imparting healthcare services (Nishtar, 2010a).   
At the primary care level, the government healthcare facilities are short of staff with 
poor supply of medicines. This results in patient’s access to low-quality private 
clinics or to secondary and tertiary care facilities, which are coping up with primary 
care problems, and thus, further weaken the tertiary care services (Tarn et al., 2008; 
Nishtar, 2010a). This, therefore, is reflective of compromised healthcare delivery 
system (Tarn et al., 2008; Nishtar, 2010a).  
1.3.3 Health care spending and drug expenditure 
 
Public health expenditure is low in Pakistan; as 3.5% of the public budget is spent on 
health, and public health expenditure only accounts 0.7% of Gross Domestic Product 
(GDP). National public expenditure on health is USD 4 per capita while total 
expenditure on health is USD 18 per capita (ADB, 2005). The per capita drug 
spending in Pakistan is alarmingly low i.e. around USD 12.57 in 2008 and which is 
now more reduced to USD 9.84 in 2009. The private spending accounts for 86% of 
the total healthcare expenditure (BMI, 2010) . In terms of healthcare finances, more 
than 80% of the medicine expenditures are Out-of-Pocket (OOP).  
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1.3.4 Social health insurance 
 
Social health insurance (SHI) schemes are considered realistic when national 
coverage is comparatively far-reaching, thus making it realistic for higher earners to 
fund lower earners. Like many developing countries, coverage under social health 
insurance schemes in Pakistan is drastically low, and avoidance of contribution is a 
problem. This is most likely because the scheme lacks the vital flexibility to cater the 
specific healthcare needs and diverse contributory competences of heterogeneous 
population groups. To be precise, SHI is still in the preliminary stage and covers only 
5% of the population of Pakistan (ADB, 2005). 
1.3.5 National health policy 
 
In 1978, Pakistan decided to adopt the WHO strategy of “Health For All (HFA) by 
the year 2000” (Ali, 2000; Pakistan, 1997). The Government of Pakistan then 
declared its first plan for a National Health Policy (NHP) in January 1990 (Pakistan, 
1990) which aimed to give universal health coverage in accordance with the strategy 
HFA 2000.  In 1997 the NHP was renewed and upgraded in line with modern health 
standards (Pakistan, 1997). The Government of Pakistan put forward its third NHP in 
2001 by accepting the need of a more detailed health policy to address health 
problems and improve life conditions. In 2008, Ministry of Health, has made a 
Health Policy Task Force (HPTF) and recently with their initiation the Ministry of 
Health (MoH) Government of Pakistan has stepped up efforts to articulate the NHP 
2010 (Nishtar, 2010b). 
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1.3.6 National drug policy 
  
In 1997 National Drug Policy (NDP) was announced but was failed to deliver 
quality-assured essential drugs to the people of Pakistan (Network, 1998; MOH, 
1997). This is simply because of poor execution of the policy. Moreover, the 
interpretation of policy is generally observed for individual interest rather than public 
welfare (Nishtar, 2010a).  
1.3.7 Pharmaceutical industry 
 
Pakistan is a densely populated country with a notable economic progress and a 
rapidly evolving pharmaceutical market. The pharmaceutical industry in Pakistan is 
worth around USD 1.18 billion showing a yearly development of 9.4%. In a number 
of more than 650 registered pharmaceutical companies in Pakistan(BMI, 2010), there 
are about 31 multinationals enjoying over 53.3% of market share while the remaining 
46.7% share is in the hands of national pharmaceutical units (IMS_Health, 2007). 
The pharmaceutical sector of Pakistan has strong influence on health sector and is a 
key generator of foreign exchange (BMI, 2011). It is foresighted that pharmaceutical 
sector of Pakistan has full potential to hike exports to more than USD 600 million by 
2010 (Syed, 2007). Although, the market of pharmaceutical industry is expanding at 
the rate of 20 per cent annually, about half of the population has so far no access to 
modern medicines (Correspondent, 2008). At present the generic medicine market in 
Pakistan is 1.341 billion US dollars and this would be expected to reach new heights 
on account of long overdue new Essential Drug List (EDL) which will comprise of 
generic medicines only (BMI, 2010). Keeping in view the demand for cost effective 
generic medicines in the country for their quality utilization, this will strengthen 
through systematic plan of action. 
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1.4 Problem statement 
 
In Pakistan 77% of the population has to endure out-of-pocket payment for 
healthcare services (WHO, 2000a; WHO, 2004). Affordability of medicines is a 
major issue in Pakistan, in which more than 44% of the population lives below the 
poverty line (Khan, 2006). In spite that the prices of medicines are fixed by the 
Federal Ministry of Health on the recommendation of Price Recommendation 
Committee (PRC), medicines enjoy a free system through which increment in prices 
is a common feature at regular intervals. Keeping in view the rising costs, the 
utilization of cost effective alternatives, which could be one of the best options in 
these scenarios, is notably low; i.e. the use of generics is even less than 50% 
(Memon, 2001). Underutilization of generic medicine and the factors affecting 
underutilization are neglected areas in Pakistan. Although there have been several 
studies from developed and developing countries addressing the factors responsible 
for underutilization of generic medicines, none has specifically focused in the 
context of Pakistan. With local pharmaceutical industry holds more than 50% of 
market share by volume coupled with the market of Pakistan flooded with branded 
generics, research into the factors affecting underutilization of generics is imperative.   
Moreover, government policies consider risk perceptions, and the perception of 
different stakeholders towards the efficacy and safety of products can affect the 
development and application of regulatory framework. Therefore, it was decided to 
conduct a cross-sectional, descriptive study by using both qualitative and quantitative 
research methods. Semi-structured interviews will be conducted to explore in-depth 
information from different stakeholders. These interviews will be analyzed to 
develop the items for quantitative instruments or questionnaires. These 
questionnaires will then be administered to different stakeholders. Moreover, to 
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change the established prescribing and dispensing behavior is a difficult task. The 
current study also attempts to interlink pharmacy students in their academic training 
towards generic medicine use. In order to sensitize the pharmacy students towards 
generic substitution and cost-effective dispensing during their academic training 
years this study is one such attempt and explores the understanding and perception of 
final year pharmacy students regarding generic medicines.  
1.5 Rationale of the study 
 
There are strong justifications for conducting this study. Increased generic drug use 
is an important means of controlling drug costs without compromising quality of care 
(Fischer & Avorn, 2004; Kohl & Shrank, 2007) and research suggests that overall 
drug spending could be reduced to more than 10% by using available generics (Haas 
et al., 2005).  
Several studies have been conducted globally regarding the perception and 
acceptance of generic drug use in health professionals. In the developing region very 
few studies have evaluated the views and attitudes of healthcare professionals and 
consumers in this regard; although generic drug utilization is found to be lower in 
this region (De Costa et al., 2008; Naseeb & Nasser, 2005; Birkett, 2003).  
In Pakistan during the fourth five-year plan a scheme of generic nomenclature i.e. 
Generic Name Act was launched. Inappropriate product strategies of domestic 
manufacturers as well as suspension of manufacturing licenses of 38 domestic 
manufacturers for the production of substandard drugs were observed at that time 
(Quraeshi et al., 1983). Consequently, lack of confidence was developed for generic 
medicines (Quraeshi et al., 1983). During the last decade World Health Organization 
(WHO) reported that less than 50% of the medicines are prescribed as generics in 
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Pakistan (WHO, 2004 ). In the context of present scenario of pharmaceutical market 
of Pakistan the total market share of domestic industry is 70-85% (by volume) and 
55% (by value). In the preceding years, the patent expiry of some major innovators is 
going to benefit the generics-dominated domestic industry (BMI, 2010; PPMA, 
2007). Therefore, it is pertinent to ascertain the knowledge, views and attitudes of 
healthcare professionals, pharmacy students and consumers towards generic 
medicine utilization.  Factors preventing people from using generic medicines and 
making the prescribers and providers hesitant to prescribe and dispense generic 
medicines are unexplored arenas in the context of Pakistan. Keeping in view this 
background and the paucity of data, this study is aimed to explore the combination of 
factors affecting the utilization of generic medicines among the consumers as well as 
prescribing and substitution by healthcare providers. 
1.6 Objectives 
1.6.1 General objective 
    
 The study is aimed to develop a planned way for the quality use of generic 
medicines.  
1.6.2    Specific objectives 
 
In order to achieve the above aim this study was performed to  
i) evaluate the knowledge, perception and attitude among general 
practitioners 
ii) evaluate knowledge,  perception and attitude among pharmacists 
iii) evaluate knowledge, perception and attitude among consumers 
iv) evaluate knowledge, perception and attitude among pharmacy students 
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1.7 Contribution of the study  
 
Generic medicines will help to establish the relative importance of acceptance of 
generics in Pakistan where previously no study have addressed this issue. The 
evaluation of knowledge, perception and attitude of prescribers, providers and 
consumers will attempt to improve the understanding and views towards generic 
medicines among all stakeholders. The study will also help to highlight the issues 
hindering the use of generic medicines. This study will provide a framework within 
which the government would have an idea about different stakeholders 
understanding and perspectives on generic medicines and can bring forth educational 
outreach program for them, which in turn, can cause judicious use of generic 
medicines.  
The study will sensitize the government to streamline the registration process for 
pharmaceuticals ensuring generic drugs must meet high-quality standards. This study 
will provide baseline data to the government to assist policy makers in developing 
appropriate strategies to promote the quality use of generic drugs, thus emphasizing 
the need for generic medicine policy. This study will help to construct strong alliance 
among provider, prescriber, and consumer who have a commitment to promote 
quality use of generic medicines.  
In addition, exploring the understanding and views of pharmacy students about 
generic medicines will help pharmacy curriculum developers to include aspects on 
generic medicine issues in Doctor of Pharmacy (Pharm D) curriculum.  This 
inclusion will not only support the initiation of substantial policy-related discussion 
but generate the importance of generic medicine utilization in pharmacy students, 
right before the start of their professional career. 
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1.8 Organization of the thesis 
 
Chapter 2 of the thesis, the Literature review is an overview of the chronological 
outline of internationally conducted studies. This chapter gives a detailed analysis of 
the research studies evaluating the knowledge, perception and attitudes of general 
practitioners, pharmacists, consumers and pharmacy students towards the 
prescribing, dispensing and utilization of generic medicines in developed, transitional 
and developing economies.   
Chapter 3 of the thesis, Research methodology gave a comprehensive account of 
both qualitative and quantitative methods used in the current research project. The 
chapter also highlighted the reasons to use both these methods in the current research 
project. In addition, to that, different sampling strategies and the issue of validity and 
reliability are also discussed.  
Chapter 4 of the thesis, provided a description of the knowledge, perception and 
attitude of general practitioners towards generic medicine prescribing. This chapter 
included the methods, data analysis, results and discussions in a step-wise approach 
of qualitative method followed by quantitative method. The last part of this chapter 
gives a summarized view of the findings in the form of conclusion. 
Chapter 5 of the thesis gave an explanation of the knowledge, perception and attitude 
of pharmacists towards generic medicine dispensing and generic substitution. A 
sequential approach of qualitative research followed by quantitative research was 
adopted.  Each research is comprised of methods, data analysis, results and 
discussions. Conclusion is also included as the last part of this chapter. 
Chapter 6 of the thesis provided a detailed description of the knowledge, perception 
and attitude of consumers towards generic medicine utilization. This section also 
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covered methods, data analysis, results and discussion under both qualitative and 
quantitative approach sequentially. Conclusion is the last section of this chapter. 
Chapter 7 of the thesis evaluated the knowledge, perception, and attitude of 
pharmacy students towards generic medicine. This chapter highlighted both 
qualitative and quantitative approaches in a phase-wise manner. Both the research 
approaches comprised of methods, data analysis, results and discussions with 
conclusion as the last part of this chapter. 
Chapter 8 drew an overall conclusion of the research project and highlighted 
recommendations as well as limitations in the study. 
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The coherent framework for literature review followed a chronological development 
of the related studies. A literature review matrix (Garrard, 2007) was also created to 
assemble the information extracted from each study. The matrix is placed in the 
spreadsheet format in the Appendices section of thesis (Appendix 2-4). 
2.1 Knowledge, perception and attitude of general practitioners 
 
A large body of literature highlighted prescriber’s knowledge, perception, attitude, 
practices, beliefs and opinions towards generic medicine prescribing. A thorough 
review of the previously published studies is compiled in the chronological order.  
2.1.1 1980-1990 
  
Bearden and Mason (1980) reported contributory factors which served as 
determinants to support generic drugs (Bearden & Mason, 1980).  In this study the 
outcomes were reported as econometric models, conclusive of factors affecting 
physicians’ prescribing decisions (Bearden & Mason, 1980). 
In another study in USA more than 60% of the family physicians showed good 
confidence to prescribe generic medicines regularly. In spite of that only slightly 
more than one fourth of the respondents admitted to prescribe mostly generic drugs 
(Bower & Burkett, 1987). Interestingly, among those 26.9%, generic prescribing was 
more extensive among residency trained family physicians. They reported negligible 
role of drug company representatives as information providers but physicians were 
found to be voracious readers of New England Journal of Medicine and the Medical 
Letter (Bower & Burkett, 1987). The reason of linkage of extensive generic 
prescribing with reading of medical journals was not mentioned in the study. 
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In another study done in New Zealand the authors expressed uneasiness on the 
government proposal to allow generic substitution by pharmacists (Tilyard et al., 
1990). A survey of 200 general practitioners was conducted to investigate their views 
on the utilization of generic medications and generic substitution. One hundred and 
eighty-two completed questionnaires were included in the analysis. Although 67% of 
general practitioners admitted that they prescribe generic medicines, a large majority 
of them showed their disagreement towards generic substitution without doctors’ 
consents. More than 25% of the respondents reported about generic-medicine related 
problems in 85 cases in their practice (Tilyard et al., 1990). A few of these were 
related to being less safe and efficacious, which in turn, made the prescriber reluctant 
to prescribe with full confidence in generics. 
2.1.2 1991-2000 
 
There were only three studies published in this decade and encompassed only 
knowledge and attitudes of resident physicians and general practitioners towards 
generic medicine prescribing. 
In a study done in USA knowledge and attitudes in a convenience sample of resident 
physicians towards generic drugs were evaluated. Three-quarters of the resident 
physicians believed that both generic and brand name medicines are of same 
efficacy. Despite that, it was noted that psychiatry residents were more inclined to 
prescribe brand name medicines (Shulkin et al., 1992). 
An attitudinal study in 39 General Practitioners in UK evaluated the attitude and 
behavior about generic drug prescribing and focused on five particular generic drugs 
and their branded counterparts (Turnbull & Parsons, 1993 ). Their attitudes were 
dependent on features of products like therapeutic category and dosage form 
 16
complexity. Diverse attitudes were reported depending on their practice 
characteristics. Physicians working without partners showed aversion to generic 
prescribing due to greater risk perception. Influence of brand loyalty and its 
implementation in practice were more marked among those GPs who frequently met 
more medical representatives as compared to their peers practicing in partnerships. 
The physicians with higher number of years practicing in general practice were more 
inclined to prescribe brand names (Turnbull & Parsons, 1993 ). 
Another attitudinal study covering beliefs, knowledge and experiences with generic 
drugs and generic substitution was done in USA (Banahan & Kolassa, 1997). The 
overall mean score on attitudinal items indicated neutral attitudes regarding generic 
substitution and moderately high concerns about substitution of critical dose drugs. 
More than 40% of the physicians indicated strong acceptance of generic drugs and 
showed least concern for critical dose drugs (pro substitution group). Interestingly, in 
this study more than 50% of the physicians were classified as ‘antisubstitution 
group’. The antisubstitution group perceived patients, managed care organizations, 
and prescription prices as pressurizing factors to allow and facilitate generic 
substitution. More than 60% of the physicians admitted to be ignorant about the 
variation in bioavailability of generic drugs allowed by Federal Drug & 
Administration (FDA) (Banahan & Kolassa, 1997). 
2.1.3 2001-2010 
 
A study conducted in early 2000 on 600 ambulatory general practitioners in South-
Eastern France showed good willingness to prescribe generics (Paraponaris et al., 
2004). The response rate was found to be 55.76%. More than 75% of the general 
practitioners showed their inclination to write prescriptions using International Non 
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Proprietary Name (INN). Physicians’ sources of information played a major role in 
decision to prescribe by INN. Moreover, different types of access to information 
inculcated willingness or reluctance to prescribe generics. This study also highlighted 
that GPs working in low-income settings have a deep insight to economic barriers 
with regard to the delivery of drugs and in an attempt to prevent this, they prescribe 
INN (Paraponaris et al., 2004). 
The American Association of Retired Persons (AARP) conducted  web-based survey 
on the practicing physicians in United States (Barrett, 2005) . Electronic invitations 
were sent to 2,050 physicians. 425 surveys were completed. Based on these numbers, 
the response rate was 21%. Most of the physicians supported the use of generic 
substitutes, dependent on their availability and appropriateness. More than 70% of 
the physicians agreed to be knowledgeable about the price differences between 
generic and brand name drugs. Medical representatives from brand name drug 
companies often paid visits and give free drug samples on a weekly basis as reported 
by 80% of the physicians (Barrett, 2005). On the contrary representatives from the 
generic drug companies never visited the physicians. The physicians also denied 
receiving free samples from generic drug manufacturers.  Most of the physicians 
admitted pressure by patients, insurance companies and healthcare plans in 
prescribing generic drugs (Barrett, 2005).  
In a study conducted in Slovenia attitudes of GPs towards generic prescribing was 
evaluated (Kersnik & Peklar, 2006). Awareness regarding costs of prescribed drugs 
in the respondents found to be high and more than 75% of them admitted that 
escalated prices of prescribed drugs posed a major problem to sustain healthcare 
budget. Educational outreach to GPs inculcated generic prescribing practices in 
doctors. A very large number of respondents (97%) opined to welcome expert drug 
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consultant from insurance institute (Kersnik & Peklar, 2006). Moreover, in the study 
the respondents showed their willingness to use generic drugs provided they are 
found to be cheaper to up to 25-35% than the branded counterparts (Kersnik & 
Peklar, 2006).  
In one of the studies in Malaysia 15 doctors employed in various government 
hospitals of Sarawak were interviewed (Run et al., 2006). The study identified 
multitude of factors like the type of illness and drugs, the patient, the doctors, 
environment, and policies for doctors’ prescribing decisions. Interestingly, the study 
did not highlight academic detailing as an important reason for prescribing drugs. 
Although in this study generic drugs were admitted as affordable, still lack of quality 
control and uncertain efficacy were perceived as hindering factors to prescribe 
generic drugs.  
In-depth semi-structured qualitative interviews were conducted in 10 Australian GPs 
to seek their perception and attitude towards generic prescribing (Hassali et al., 
2006b) . Mixed attitudes were observed towards generic prescribing. Due to generic 
substitution policy some were wary about their personal role as prescriber and 
showed concern about patient confusion which may arise from substitution. All the 
respondents were unaware of the bioequivalence acceptability standards for generic 
drugs (Hassali et al., 2006b) . 
Generic substitution was instituted in Finland in early 2000 as a cost-containment 
measure. Finnish pharmacists were instructed to substitute the cheaper alternatives 
for prescribed medicines provided the customer or the physician did not ask to 
refrain from substitution (Heikkila et al., 2007). Structured interviews with 25 GPs, 8 
psychiatrists, 8 geriatrists, and 8 internists were conducted one year after the generic 
substitution introduced. Generic substitution as a good reform measure was opined 
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by more than 85% of the physicians while the rest considered generic substitution a 
failure reform (Heikkila et al., 2007). More than 50% of the respondents considered 
beta blockers, lipid lowering agents and selective serotonin reuptake inhibitors not to 
be interchangeable with cheaper alternatives (Heikkila et al., 2007) . 
According to changes in Pharmacy Act in Jamaica in 1993 pharmacists were 
permitted to do generic substitution with some reservations. This was only allowed 
provided the physician did not mention ‘no substitution’ on prescription (Gossell-
Williams, 2007) . In context to that a survey was conducted on 60 physicians from 
various specialties to explore their opinion about acceptance as well as to investigate 
their perception about generic drugs (Gossell-Williams, 2007) . Nearly half of the 
physicians indicated cost effectiveness of cheaper alternatives a major factor in 
prescribing generics. More than 30% of the physicians related clinical problems with 
generic substitutes in at least one of their patient. Good acceptance of generics was 
noted by responding physicians. Conclusively, physicians were willing to accept 
generic substitution provided their confidence in therapeutic equivalence can be built 
(Gossell-Williams, 2007). 
In another study in US physicians cited major concerns for the efficacy and safety of 
generic alternatives of antiepileptic drugs (AED) (Berg et al., 2008). More than 60% 
of the physicians revealed that a breakthrough seizure was elicited in their patients 
after switching from brand AED to generic AED (Berg et al., 2008). Majority of the 
physicians (75%) showed their concern about the efficacy of generic AED. As 
patient’s welfare is of prime importance more than 80% of the physicians were not in 
favor of allowing generic substitution without their consent (Berg et al., 2008).  
In British Columbia, Canada generic substitution policies were introduced in 1994.  
Drug benefit program for elderly adults ‘PharmaCare’ introduced a Reference Drug 
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Program (RDP). In RDP generic substitution is extrapolated to therapeutic 
substitution which means that drugs in reference drug group are considered to be 
interchangeable based on the equivalence of their clinical effectiveness and safety 
(Schneeweiss et al., 2002). A telephonic interview-based study was designed to 
assess the opinion of GPs towards generic substitution and RDP in British Columbia. 
Precisely, GPs showed positive attitudes and beliefs about the economic 
appropriateness of generic substitution and RDP. In terms of clinical appropriateness 
of the programs they did not show much enthusiasm (Polinski et al., 2008). 
In a recently conducted study in Saudi Arabia, nearly all the physicians (n=471; 
96%) showed good understanding about the therapeutic value of prescribed generic 
drugs (Alghasham, 2009). Majority of the respondents (88%) reported understanding 
of the price difference between generic and brand name drugs and most of them 
(75%) agreed that price difference is the determinant to switch easily to a generic 
prescription. Around 80% of the physicians supported generic substitution except in 
some certain situations where brand drugs are recommended. Interestingly, 75% of 
the physicians asserted that they have never been visited by pharmaceutical 
representatives of generic drug companies. Around half of the respondents (47%) 
favored generic substitution by the pharmacist only on the instruction of physicians. 
Around 50% of the physicians considered generic substitution a cost-containment 
strategy (Alghasham, 2009). Most physicians cited positive attitude towards the role 
of the government for checks and balances on the pharmaceutical industry as well as 
to persuade the physicians for generic prescribing. To be precise, this study 
highlighted good understanding and positive attitude of physicians towards generic 
prescribing (Alghasham, 2009).  
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In an attempt to explore the perceptions of physicians in Basrah, Iraq semi-structured 
qualitative interviews were conducted with 10 respondents (Sharrad et al., 2009). 
Thematic content analysis identified multiple themes; mainly related to the factors 
affecting generic medicine prescribing. This study highlighted that the medicine 
availability in Iraqi market is a major factor in the prescribing decisions. All the 
physicians showed strong dissatisfaction over the plight of presence of counterfeit 
drugs in Iraq. Drug promotional strategies by the industries were accounted by the 
physicians to have a strong influence on prescribing decision. Majority of physicians 
were not in favor of generic substitution by the pharmacist in the absence of doctors 
or physicians consent and agreement. Conclusively, physicians were willing to 
prescribe generic medicines (Sharrad et al., 2009). 
In European countries generic medicine market exhibited a non-uniform pattern due 
to different policies (Simoens & Coster, 2006).  As Greece exhibits a weak 
penetration of generic medicines in their pharmaceutical market a study was directed 
to explore to prescribing patterns of Greek physicians as well as the factors hindering 
and favoring their prescribing decisions (Tsiantou et al., 2009). Factors as sources of 
information in prescribing were peer-reviewed publications, medical representatives 
and electronic databases. Around 75% of the physicians cited that sales 
representatives do not influence their prescribing decisions. Although patient 
complained about the drug cost, still physicians admitted that they do not interfere in 
their prescribing decisions. More than 70% of the respondents claimed that they 
seldom changed their prescribing habits except in few instances like manifestations 
of side effects, drug withdrawal of the market, etc. Insurance coverage and income of 
the patient coupled with drug cost were cited as major determinants of drug choice 
(Tsiantou et al., 2009). Majority of the Greek physicians were in favor of 
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enforcement of INN system (n=725; 60.2%) as they showed positive perception 
towards the quality of generic medicine in Greece. Interestingly, in spite of all these 
facts Greek physicians did not prescribe generic medicines. Senior physicians 
showed higher probability of prescribing generics as compared to young ones. In a 
nutshell, a policy to promote generics in Greece can be a stimulus for physicians 
generic prescribing (Tsiantou et al., 2009).  
In another comparative detailed study among Greek and Cypriot physicians ‘clinical 
effectiveness’ was cited as the most important factor in their prescribing decisions 
(Theodorou et al., 2009). Cost was cited as another highly important influential 
factor in more than 90% of the Greek physicians and 27% of Cypriot physicians. 
More than 65% of both Greek and Cypriot physician stated insurance coverage of the 
patients as one of the major determinants in prescribing. Although majority of the 
physicians from both the countries admitted quality, safety and effectiveness of 
generics as ‘acceptable’, still only Cypriot physicians generally prescribed them 
(Theodorou et al., 2009) .  
The New Malaysian National Medicine Policy recommended generic prescribing and 
substitution to improve the affordability of medicines. In context to that the physician 
is heavily burdened, and thus, a study was aimed to explore the understanding of GPs 
in Malaysia (Chua et al., 2010). More than 85% of the GPs admitted to prescribe 
generics in their practice. Interestingly the respondents defective understanding of 
Malaysia’s National Pharmaceutical Control Bureau (NPCB) regulatory limit for 
bioequivalence but nearly half of the GPs believed that a generic medicine is 
bioequivalent to brand name medicine (Chua et al., 2010). More than 80% of the 
GPs believed that a standard guideline on brand substitution process is the need of 
time. Lucrative schemes in the form of product bonuses from drug companies, drug 
 23
promotion and socioeconomic factors were reported to influence the choice of 
prescribing (Chua et al., 2010) .  
2.1.4 Conclusion 
 
In general physicians accepted generic substitution owing to policy pressure and 
economic scenarios but they still feel wary about the quality, reliability and 
‘switching phenomenon’ of specific drug categories. These issues restrict the 
phenomenon of adoption of generic prescribing and substitution at its fullest, thus 
result in an increased burden on healthcare costs. In order to rectify the quality and 
reliability issues of generic medicines, co-operation among every stakeholder be it 
government, educator, professional organizations and consumer associations is of 
prime importance. Regulatory bodies should assure every stakeholder that generics 
are produced and kept according to the required standards. Professional organizations 
should declare their views from generic practices in their policy statements and 
consumer organizations must demand to be informed about the medicines they will 
pay for, especially in cases of OOPs.  
To be precise and as evident from the cited studies, only a couple of studies have 
been conducted in transitional and developing economies and therefore, there is an 
urgent need to address the contemporary issues surrounding generic medicine 
prescribing in the context of Pakistan.  
2.2 Knowledge, perception and attitudes of pharmacists towards 
generic medicine use and generic substitution 
A large body of literature highlighted community and hospital pharmacist’s 
knowledge, perception, attitude, practices, beliefs and opinions towards generic 
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medicine dispensing and substitution. A thorough review of the previously published 
studies encompassing these above variables is compiled under chronological order.  
2.2.1 1980-1990 
 
In order to reduce the burden of health expenditure from the consumer, Drug Product 
Selection (DPS) legislation was passed in US, which gave liberty to the pharmacist 
to substitute a generic drug to a brand-name written prescription (Goldberg et al., 
1979). Mason and Bearden conducted a study on 118 practicing pharmacists in the 
state of Alabama (Mason & Bearden, 1980). Majority of the pharmacists suggested 
that they should have the substitution rights and they considered themselves 
superiorly trained than physicians in drug product selection. In case of generic 
prescribing, which is a common modality by the physicians, most of the pharmacists 
perceived fewer risks for consumers. In case of generic dispensing most of the 
pharmacists were apprehensive about facing paramount potential for liability. 
Pharmacists expressed satisfaction to dispense drugs manufactured by reputable 
manufacturers (Mason & Bearden, 1980). 
Similarly in the same period after the enactment of DPS legislation, Carroll and her 
associates conducted two studies in six different states of US to explore the perceived 
risks associated with the reluctant behavior of pharmacists towards generic 
substitution (Carroll et al., 1986; Carroll & Wolfgang, 1991). In one of the study 
conducted in the state of Georgia, a random sample of 600 pharmacists was selected 
(Carroll et al., 1986). A response rate of 69.5% was achieved. The analysis of 321 
usable questionnaires highlighted the use of non-therapeutic and bioinequivalent 
products, concerns about quality, and time frame required to motivate the customer 
for substitution as most important perceived risks and generate reluctance in 
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pharmacist’s behavior to substitute a product. Efforts on assuring the quality of 
generic products and their bioequivalence by sending promotional messages for 
comparative bioavailability data as well as building confidence in quality control 
steps taken by manufacturers were some of the suggested measures, which might 
lessen the reluctance of pharmacists to substitute generically (Carroll et al., 1986). In 
another study Carroll and her associates mailed the questionnaire to 1,007 
pharmacists in five different states of US i.e. Kentucky, New York, Mississippi, 
California, and Texas (Carroll & Wolfgang, 1991). With a response rate of 59%, 401 
usable questionnaires were analyzed and gave the same results as the previous study 
done in Georgia. Precisely, pharmacist’s behavioral decision to substitute seems to 
be governed by both expected benefits and expected risks (Carroll & Wolfgang, 
1991).  
In another study conducted in Ohio, factors were evaluated to explore the decision-
making behavior of pharmacists in the selection of generic pharmaceuticals (Segal et 
al., 1989). This study tried to identify the criteria that affect pharmacists’ decisions to 
stock generic pharmaceuticals in pharmacies as well as to recommend them to 
patients. A random sample of 500 pharmacist-owners and managers of Ohio 
independent community pharmacies were invited to participate in the study. The 
questionnaire was developed after in depth interviews with 27-member Co-operative 
of Ohio Pharmacies (Segal et al., 1989). The questionnaire was then mailed to all 
invited participants. A total of 298 usable questionnaires highlighted that more than 
20% of the respondents disagreed or strongly disagreed that FDA approval is a 
guarantee of quality for generic products. More than 20% of the respondents 
considered FDA Orange Book extremely important or important as the determinant 
of overall quality of generic products. Promptness of shipment, consistent 
